DermaSensor
DermaSensor Raises $16M in Series B
DermaSensor Raises $16M in Series B
DermaSensor has successfully raised $16M in a Series B at a $85M valuation led by Healthtech Capital, LSP.
Company Overview
DermaSensor is a HealthTech company headquartered in Miami, FL, founded in 2020 with 70+ employees.
AI-powered skin cancer screening device for early detection
Fundraising Details
- Amount Raised: $16M
- Round Type: Series B
- Valuation: $85M
- Date: 2025-10-06
- Investors: Healthtech Capital, LSP
About DermaSensor
AI-powered skin cancer screening device for early detection The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Miami, FL
- Founded: 2020
- Team Size: 70+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in DermaSensor's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. DermaSensor's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $85M valuation marks an important milestone for DermaSensor, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, DermaSensor is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-10-06. For more information about DermaSensor, visit their headquarters at Miami, FL.
Company Info
Share
Related Reports
Infisical Raises $40M Series B for AI Agent Security Infrastructure
Infisical raised a $40 million Series B at a $600 million valuation, led by Elad Gil, to expand security infrastructure for AI agents.
Vera Health Raises $28.5M Series A for Clinical AI Search
Vera Health raised a $28.5 million Series A led by Threshold Ventures to further develop its clinical evidence infrastructure and expand into additional healthcare markets.
Omnichat Raises US$10M Series A for Agentic Customer Experience Platform
Omnichat raised a US$10 million Series A led by Openspace Capital to scale its agentic AI platform, deepen R&D on Omni AI Agents and expand globally.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free